Clinical Trial Update: Clinical Utility of Pharmacogenomics of Psychotropic Medications [Phase 4]

View source ↗

Summary

Phase 4 clinical trial investigating pharmacogenomics utility in psychotropic medications was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pain
• Psychiatric Disorders

Snippet

Sponsor: Oregon Health and Science University | Conditions: Psychiatric Disorders, Pain | Phase 4 | Status: WITHDRAWN